Summary
Medtronic plc (MDT) announced on January 11, 2016, updates to its capital allocation plans and a tightening of its fiscal year 2016 earnings per share (EPS) guidance. These updates were communicated via a press release issued in conjunction with an anticipated presentation by CEO Omar Ishrak at the 34th Annual JP Morgan Healthcare Conference. Investors should note that the company is providing more specific financial outlook details.
Key Highlights
- 1Medtronic updated its capital allocation strategy.
- 2The company revised its fiscal year 2016 EPS guidance, tightening the range.
- 3These updates were shared via a press release on January 11, 2016.
- 4The information was presented by CEO Omar Ishrak at the JP Morgan Healthcare Conference.
- 5A webcast of the presentation was made available on the company's investor relations website.
- 6An archive of the webcast will also be available post-event.
Frequently Asked Questions
The primary purpose of this 8-K filing is to publicly disclose updates to Medtronic's capital allocation plans and to provide a more precise earnings per share (EPS) guidance for fiscal year 2016.
The detailed information was released in a press release furnished as Exhibit 99.1 to this 8-K filing. Additionally, the company's CEO presented this information at the JP Morgan Healthcare Conference, and a webcast of this presentation is available on Medtronic's investor relations website.
No, this filing explicitly states that there are no Financial Statements of Businesses Acquired, Pro Forma Financial Information, or Shell Company Transactions included. The focus is solely on capital allocation and EPS guidance updates.
The press release and updates were issued on January 11, 2016, and discussed at the JP Morgan Healthcare Conference on the same day.